The Plasmodium falciparum Malaria M1 Alanyl Aminopeptidase (PfA-M1): Insights of Catalytic Mechanism and Function from MD Simulations by Jones, Peter M. et al.
The Plasmodium falciparum Malaria M1 Alanyl
Aminopeptidase (PfA-M1): Insights of Catalytic
Mechanism and Function from MD Simulations
Peter M. Jones
1,2, Mark W. Robinson
2, John P. Dalton
3, Anthony M. George
1,2*
1School of Medical and Molecular Biosciences, Sydney, New South Wales, Australia, 2i3 Institute, University of Technology Sydney, Sydney, New South Wales, Australia,
3Institute of Parasitology, McGill University, Montreal, Quebec, Canada
Abstract
Malaria caused by several species of Plasmodium is major parasitic disease of humans, causing 1–3 million deaths worldwide
annually. The widespread resistance of the human parasite to current drug therapies is of major concern making the
identification of new drug targets urgent. While the parasite grows and multiplies inside the host erythrocyte it degrades
the host cell hemoglobin and utilizes the released amino acids to synthesize its own proteins. The P. falciparum malarial M1
alanyl-aminopeptidase (PfA-M1) is an enzyme involved in the terminal stages of hemoglobin digestion and the generation
of an amino acid pool within the parasite. The enzyme has been validated as a potential drug target since inhibitors of the
enzyme block parasite growth in vitro and in vivo. In order to gain further understanding of this enzyme, molecular
dynamics simulations using data from a recent crystal structure of PfA-M1 were performed. The results elucidate the
pentahedral coordination of the catalytic Zn in these metallo-proteases and provide new insights into the roles of this
cation and important active site residues in ligand binding and in the hydrolysis of the peptide bond. Based on the data, we
propose a two-step catalytic mechanism, in which the conformation of the active site is altered between the Michaelis
complex and the transition state. In addition, the simulations identify global changes in the protein in which conformational
transitions in the catalytic domain are transmitted at the opening of the N-terminal 8 A ˚-long channel and at the opening of
the 30 A ˚-long C-terminal internal chamber that facilitates entry of peptides to the active site and exit of released amino
acids. The possible implications of these global changes with regard to enzyme function are discussed.
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Introduction
Malaria is a major cause of human morbidity and mortality
worldwide with an estimated 1–3 million deaths each year (http://
www.who.int/malaria/wmr2008/malaria2008). Four Plasmodi-
um species commonly infect humans, but P. falciparum is
responsible for most deaths [1]. With the declining efficacy of
affordable antimalarial drugs such as sulfadoxine-pyrimethamine
due to the emergence of drug resistant parasites, the current
recommended treatment for uncomplicated malaria in most
countries relies on an artemisinin combination therapy (ACT).
Recent reports suggesting a decreased efficacy of these ACTs
[2,3,4] is of major concern and highlights the urgent need for next
generation antimalarial agents that target new parasite systems.
Most anti-malarial drugs target the asexual intra-erythrocytic
stages of the Plasmodium parasite. This highly metabolic develop-
mental stage is responsible for all the clinical symptoms attributable
to malaria [5].Insidethe erythrocyte malaria parasitesuse proteases
to degrade 65–75% of host cell haemoglobin in a process that
ultimately results in the release of free amino acids [6]. The initial
steps in this process take place in a specialized digestive vacuole
(DV) at pH 5.2 and involve aspartic proteases (plasmepsins I, II, IV
and histo-aspartic protease), cysteine proteinases (falcipains 2, 29
and 3), a metallo-protease (falcilysin) and a dipeptidyl aminopep-
tidase I, or cathepsin C [6,7,8]. The combined action of these
proteases degrades the haemoglobin into small peptides or
dipeptides that are suggested to be transported to the parasite
cytosol for final processing by neutral exo-aminopeptidases
[9,10,11]. Exo-aminopeptidases are essential in releasing amino
acids from hemoglobin-derived peptides and are central to the
growth and development of malaria parasites in the erythrocyte as
the free amino acids are used by the parasite in protein synthesis
[6,12]. One of the pivotal aminopeptidases involved in this process
is the Plasmodium falciparum alanyl aminopeptidase, termed PfA-M1
because it belongs to clan MA, family M1 aminopeptidases.
Inhibitors of this enzyme prevent both the growth of malaria
parasitesinerythrocytesinculture and in vivoinexperimental mouse
models and, hence, the enzyme is considered a prime target for the
development of new anti-malaria drugs [11,13].
The PfA-M1 is encoded by single-copy gene, is a protein of
1,085 aa and molecular weight 126 kDa, but is detected as a 122-
kDa protein in membrane fractions of malaria parasites [14]. PfA-
M1 orthologues of the various rodent malaria species (P. berghei, P.
chabaudi chabaudi, and P. yoelii) share 70% identity and are most
divergent at a large non-conserved N-terminal extension (194 aa),
which contains 3 asparagine-rich low-complexity regions (LCRs)
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catalytic machinery of all malaria M1 alanyl aminopeptidases is
completely conserved [14]. Outside malaria, PfA-M1 shows closest
identity (35%) to the bacterial M1 aminopeptidases, which do not
contain the extended N-terminal domain. However, the core
structure of the clan MA, family M1 enzymes is well conserved in
bacteria, plants, insects and mammals.
A truncated form of the PfA-M1 lacking the unique N-terminal
extension (residues 195–1085, correlating with the start of the M1
aminopeptidase of Escherichia coli PepN) was expressed as a
functional recombinant form in E. coli and the purified enzyme
shown to exhibit physico-biochemical characteristics identical to
those of a naturally occurring soluble form of the PfA-M1 enzyme
in malaria cells. The X-ray crystal structure of this construct was
recently determined [15] and confirmed that PfA-M1 adopts the
bacterial aminopeptidase N-fold [16,17,18]. Thus, PfA-M1
comprises 26 a-helices and 26 b-strands arranged in four domains,
domain I–IV (Fig. 1A): an N-terminal domain (196–391, I), a
catalytic domain (392–649, II), a middle domain (650–746, III),
and a C-terminal domain (747–1084, IV). The N-terminal domain
forms a b-sandwich structure composed of three ß-sheets. The
catalytic domain, which forms an interface with all three other
domains, is an a/b structure comprising a five-stranded b-sheet
and eight a-helices. Like other M1 aminopeptidases, the enzyme
contains a single catalytic zinc ion in the active site.
The active site is found in a groove that consists of one b-strand
and three a-helices; b-strand 18 and a-helix 5 form each sidewall,
and a-helices 2 and 3 serve as the base (Fig. 1B). The site contains
thezinc-bindingmotifH
496EYFHX17KE
519and the well-conserved
G
490AMEN motif involved in substrate recognition [16,17,18]. The
catalytic zinc ion is coordinated by the Ne2 atoms of His-496 and
His-500, the carboxyl O atom of Glu-519, and a water molecule
that acts as the nucleophile that attacks the carbonyl carbon of the
substrate (Fig. 1C). This water molecule forms a metallo-bond with
the zinc ion and is also coordinated by Glu-497 and Glu-463.
There are two openings on the surface of the PfA-M1 enzyme
that connect to the active site cavity. The first opening (N-terminal
channel) comprises a shallow 8 A ˚-long groove at the junction of
domains I and IV. The second and larger opening (C-terminal
channel) is a 30 A ˚-long channel that is formed by the C-terminal
domain IV, which comprises 8 pairs of a-helices arranged in 2
layers to form a cone-shaped super-helical structure; this domain
also interacts with the catalytic domain II. We have proposed that
hemoglobin-derived peptides access the buried active site via the
30 A ˚ long C-terminal channel and that hydrolytically released
amino acids exit by the narrow N-terminal channel.
In order to investigate both the binding mode of a natural peptide
ligand as well as the possible effect of ligand binding on the global
dynamics and conformation of PfA-M1, we performed two 75 ns
unrestrainedall-atomMDsimulationsofPfA-M1;oneoftheenzyme
without substrate (apo-enzyme state) and the other of the enzyme
complexed with a four-residue peptide, Phe-Leu-Ala-Ser (ligand-
bound state). This ligand sequence was chosen because (a) the
coordinates of the first two residues can be derived from the X-ray
structure of bestatin-bound PfA-M1 (PDB code 3EBH), and (b) the
last two C-terminal residues complete a tetrapeptide sequence found
in human haemoglobin. Our studies provide new insights into the
structure andcatalyticmechanism of PfA-M1, which are discussed in
terms of the enzyme’s pivotal function in the malaria parasite.
Results and Discussion
Interactions of the active site zinc cation reveal the basis
of pentahedral coordination
The zinc divalent cation in the active site of PfA-M1 poses a
technical problem in MD simulations. This is because, whilst X-
Figure 1. Structure of PfA-M1 aminopeptidase N. A. Ribbon diagram of PfA-M1 (PDB code 3EBH) coloured by domain: I (blue), II (green), III
(yellow) and IV (red). Zinc ion depicted as purple sphere. Arrow indicates position of C-terminal channel opening. B. Catalytic domain II, with a-helices
coloured red, loops green and b-strands yellow. Active site residues are shown in stick form with carbon cyan, oxygen red and nitrogen blue. Zinc ion
depicted as purple sphere. The N-terminal lobe consisting of a 5-stranded b-sheet and a-helices 1–2 is to the right, the C-terminal lobe comprising a-
helices 3–8 is to the left. The active site occurs in the cleft between the N- and C-terminal lobes. C. Ligand-bound active site. Active site of the starting
structure of the ligand-bound complex used in the simulation. Ligand and active site residues are shown in stick form with carbon green (ligand) or
yellow (PfA-M1), oxygen red and nitrogen blue. The nucleophilic water is labelled ‘‘W1’’ and the ligand N-terminal amino nitrogen ‘‘N’’. Hydrogen
bonds and metallo bonds are shown as red and purple dotted lines, respectively.
doi:10.1371/journal.pone.0028589.g001
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the active site zinc [19,20], use of the standard CHARMM
forcefield parameters for zinc in MD simulations of PfA-M1
resulted in hexacoordinated zinc (data not shown). This problem
was solved by the cationic dummy atom model of Zn-ligand
interactions [21]. In this model, four cationic dummy atoms, each
with a charge of +0.5e, are tetrahedrally bonded to a central zinc
atom, thus mimicking Zn’s 4s4p
3 vacant orbitals, and imposing the
requisite orientational requirement for the ligands. The central
zinc atom is assigned only vdW parameters, its +2e charge being
distributed among the four dummy atoms, which interact with
other atoms in the protein only via electrostatic interactions. Here
we empirically modified the cationic dummy atom model for use
with our MD code NAMD 2.6, the CHARMM27 forcefield and
the PfA-M1 protein (see ‘Methods’).
Pentahedral coordination of the zinc cation was maintained
throughout the simulations of both the apo- and ligand-bound
PfA-M1 and was the same in both (Fig. 1C) with the only
difference being a second water molecule occupying approximate-
ly the same position in apo-PfA-M1 as a backbone carbonyl
oxygen in the ligand-bound complex. Table 1 shows the average
distances of the Zn-coordinating atoms to the central zinc atom in
the simulations and for comparison, those from X-ray structures of
PfA-M1 and related N aminopeptidases from E. coli and Neisseria
meningitidis. The mean distances between the Zn and its
coordinating atoms in the simulations are in good agreement
with the crystal structures. Indeed, the results match the crystal
structures in this respect as well or better than do results from
alternative schemes used for accounting for Zn coordination in
MD simulations [21,22,23].
Pentahedral coordination of the catalytic Zn was observed in
crystal structures of a number of inhibitor-bound complexes of
aminopeptidase N [16,17,18,24]. Pentahedral coordination of the
catalytic Zn is required to bind the transition state of the hydrolysis
reaction, which forms upon nucleophilic attack by a water
molecule at the carbonyl carbon of the substrate. Inhibitors such
as bestatin mimic the transition state of the hydrolysis reaction by
containing two oxygen atoms appropriately deployed to account
for the backbone carbonyl oxygen of the ligand and the oxygen of
the nucleophilic water. An interesting feature of the Zn
coordination observed in all inhibitor-bound M1 aminopeptidase
crystal structures reported is that, while the three protein atoms
that coordinate the Zn are distributed in an approximately regular
tetrahedral geometry, the two oxygen atoms of the inhibitor are
located on opposite sides of the point corresponding to the fourth
apex of a regular tetrahedron. This is shown in Table 2, where the
angles formed by the Zn-coordinating atoms are tabulated for
comparison between the crystal structures and the simulations.
The irregularity of the penta-coordinate geometry of the Zn
coordination observed in the inhibitor-bound crystal structures
could perhaps be due to steric restrictions placed on the
configuration of the inhibitor’s Zn-coordinating oxygen atoms,
although, the crystal structures of the unliganded protein do not
support this idea. Thus, although the Zn is tetrahedrally
coordinated in apo-enzyme structures, the single Zn-coordinating
water molecule found in each structure is displaced to one side of
the point corresponding to the apex of a regular tetrahedron, with
respect to the other three coordinating atoms, similarly as
observed for the ligand oxygen atoms in the inhibitor bound
structures. This is shown in Table 2 by the average of the largest
angle between the coordinating water and the coordinating
protein atoms in four apo structures of M1 aminopeptidases.
Notably, when two apo-enzyme structures of the E. coli
aminopeptidase N from different studies [16,17] are structurally
overlaid, the Zn-coordinating water molecules from each structure
also are found to be distributed to opposite sides of the point
representing the apex of a regular tetrahedron, with respect to the
three protein ligands (Fig. S1). Moreover, analogously to the Zn-
coordinating oxygen atoms of the inhibitor in the bestatin-bound
structures, one water molecule is hydrogen-bonded to Tyr-580,
while the other forms hydrogen bonds to Glu-463 and Glu-497
(PfA-M1 numbering).
Table 2 shows the mean angles between the Zn atoms and its
coordination atoms from the simulations. The data indicate that
the simulations reproduce the geometry of the pentahedral
coordination of the Zn observed in the crystal structures very
well. In the simulations, the irregular pentahedral coordination
geometry occurs because, whilst three of the apex atoms of the Zn
cation associate closely with one or other of the coordination
atoms from the protein, the fourth apex atom is ‘‘shared’’ by the
non-protein coordination atoms. This is illustrated in Table S1,
which shows the mean distances of the Zn coordinating atoms to
the proximal apex atom of the Zn cation.
As discussed above, in the crystal structures of E. coli apo
aminopeptidase N, only one water molecule is resolved in the Zn
coordination shell. Notably however, in the structure of apo-PfA-
M1, a second water molecule is located 2.62 A ˚ from the Zn. This
second water forms hydrogen bonds to Glu-463 and Glu-497 and
approximately occupies the position of the nucleophilic water, as
inferred from structures of inhibitor-bound aminopeptidase N
(Fig. 1C). In the simulation of the apo-enzyme state, two water
molecules were found to coordinate the Zn (Table 1). The water
molecule occupying the site approximately equivalent to the ligand
carbonyl oxygen (W2; Water 2 in Table 1) was found to exchange
16 times during the simulation, and to be situated significantly
further away from the zinc atom than the water molecule
Table 1. Distances between the Zn atom and its coordinating atoms
a.
E519 oe1 H496 ne2 H500 ne2 Water 1 O Water 2 O Ligand O
b
X-ray
c 2.0360.04 2.0660.03 2.0660.04 2.1260.14 - -
Apo
d 2.0460.04 2.0960.03 2.1060.03 2.0560.04 2.2960.15 -
Ligand
d 2.0560.04 2.1060.03 2.0860.03 2.1760.14 - 2.0560.09
aMean values and standard deviations are in A ˚.
bDistance between Zn and the ligand backbone carbonyl oxygen of the scissile bond.
cMean values and standard deviations obtained by averaging over 9 PDB structures of aminopeptidase N: P. falciparum (3EBH, 3EBI, 3EBG; [15]), E. coli (2ZXG; [24]), E. coli
(2HPT, 2HPO; [17]), E. coli (2DQM, 2DQ6; [16]), N. meningitidis (2GTQ; [18]). The protein atom-Zn distances are the means of 9 measurements, while the water molecule
distance is the mean distance measured from 4 unliganded structures.
dFrom PfA-M1 simulations, distances sampled every 50 ps over the 75 ns simulations.
doi:10.1371/journal.pone.0028589.t001
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exchanged once. The higher frequency of exchange of W2 is
consistent with the fact that it must make way for the ligand
carbonyl oxygen upon ligand binding. The observation from both
the simulations and crystal structures that the non-protein oxygen
atoms consistently migrate to one of two defined loci, indicates that
the active site is structured both sterically and electrostatically to
induce the irregular pentahedral coordination observed. Together,
the data suggest that the penta-coordinate geometry of the Zn
occurs because the two non-protein oxygen atoms share one of the
Zn’s vacant orbitals.
Active site residue interactions: insights into the catalytic
mechanism
The simulation of the ligand-bound protein provided unique
insights into the Michaelis complex, which differed in significant
ways from the transition state approximated by the inhibitor-
bound crystal structures. This revealed how the pentahedral
coordination of the catalytic Zn brings the nucleophilic water into
close proximity with the substrate carbonyl carbon; this is
illustrated in Fig. 2, which shows a frequency histogram of the
distances of the putative nucleophilic water oxygen to the scissile
carbonyl carbon. The combined van der Waals radii of these two
atoms in the CHARMM27 forcefield is 3.77 A ˚. In the simulation,
the average distance between these atoms was 3.23 A ˚, whilst more
than 18% of sampled distances were less than 3.1 A ˚, with a closest
measured approach of 2.75 A ˚. Thus, the simulations suggest that
pentahedral coordination of the catalytic Zn occurs in the ground
(reactant) state of the hydrolysis reaction, and facilitates progress to
the transition state by orienting the reactants i.e. directing the
uncoordinated lone pair electrons of the nucleophilic water oxygen
toward the substrate carbonyl carbon, and bringing them into
close proximity.
An interesting feature of the active site during the ligand-bound
simulation is the interactions of residue Tyr-580. From crystal
structures of inhibitor-bound E. coli aminopeptidase N, it was
inferred that the Tyr-580 hydroxyl moiety binds the substrate P1
carbonyl oxygen in the tetrahedral transition state of the hydrolysis
reaction [17]. In our simulation of the ligand bound complex, it
was observed that the mean distance between the Tyr-580
hydroxyl oxygen and the substrate P1 carbonyl carbon was
3.56 A ˚, while the mean distance between the Tyr-580 hydroxyl
oxygen and the substrate P1 carbonyl oxygen was greater at
3.88 A ˚. The approach profile of the Tyr-580 hydroxyl oxygen and
the substrate carbonyl carbon reveals a broad distribution of
distances with closest approaches down to under 3 A ˚ (Fig. 2). The
close proximity of the Tyr-580 hydroxyl oxygen and the substrate
carbonyl carbon in the Michaelis complex may facilitate
progression to the transition state, aiding the polarisation of the
substrate carbonyl O-C bond by inducing and stabilizing increased
positive charge on the carbon, thus acting to destabilize the
ground (reactant) state. This scenario supports the role proposed
for the equivalent residues in both M1 aminopeptidases [17] and
thermolysin [25] in decreasing the activation energy of the
hydrolysis reaction, in contrast to alternative schemes in which it is
suggested to protonate the P19 amide [26,27,28].
Other observations from the simulations shed important light
on the details of the catalytic mechanism and the roles of active site
residues. In inhibitor-bound crystal structures, Glu-497 is within
hydrogen-bond distance of the ligand oxygen expected to mimic
that of the nucleophilic water, and is postulated to act as the
catalytic base of the hydrolysis reaction in aminopeptidase N
[17,29], as well as other enzymes from the same superfamily
[28,30,31]. In our ligand-bound, but not the apo-enzyme
simulation, the Glu-497 sidechain undergoes a conformational
Table 2. Angles between the Zn atom and its coordinating
atoms
a.
E519 oe1
H496 ne2
H496 ne2
H500 ne2
H500 ne2
E519 oe1 Water 1 O O-Zn-O
b
X-ray
c 109.762.4 101.263.2 102.263.2 134.3614.2 64.9610.5
Apo
d 109.868.7 97.764.1 102.066.6 - 82.266.9
Ligand
d 110.065.7 99.764.8 96.664.5 - 76.463.2
aMean values and standard deviations are in degrees.
bFor the crystal structures, the angle between the Zn-coordinating oxygen
atoms of the bound inhibitor was measured, for the apo simulation the angle
between the Zn-coordinating oxygen atoms of the two proximal water
molecules was measured, and for the ligand-bound simulation, the angle
between the Zn-coordinating oxygen atoms of the nucleophilic water and the
ligand carbonyl oxygen atom was measured.
cMean values and standard deviations obtained by averaging over 9 PDB
structures of aminopeptidase N: P. falciparum (3EBH, 3EBI, 3EBG; [15]), E. coli
(2ZXG; [24]), E. coli (2HPT, 2HPO; [17]), E. coli (2DQM, 2DQ6; [16]), N. meningitidis
(2GTQ, [18]). The protein atom-Zn angles are the means of 9 measurements,
the water 1 angle is the mean distances measured from 4 unliganded
structures. The O-Zn-O angle is the mean from 5 inhibitor-bound structures.
dFrom PfA-M1 simulations, angles sampled every 50 ps over the 75 ns
simulations.
doi:10.1371/journal.pone.0028589.t002
Figure 2. Approach profile of the nucleophilic water and Tyr-580 hydroxyl oxygens to the ligand carbonyl carbon. Smoothed
histogram plots of distances to the ligand carbonyl carbon measured in 0.1 A ˚ bins every 50 ps over the 75 ns simulation of the ligand-bound
complex. Solid line, distances to nucleophilic water oxygen; dashed line, distances to Tyr-580 hydroxyl oxygen.
doi:10.1371/journal.pone.0028589.g002
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simulation starting structure (Fig. 1C) to form a hydrogen bond
between one of its sidechain carboxylate oxygens and the
sidechain of residue Asn-468 whilst still maintaining a hydrogen
bond to the nucleophilic water (Fig. 3A). These observations
indicate that the Michaelis complex differs from the transition
state in this respect and are consistent with the idea that Asn-468
has an ancillary role in the catalytic mechanism, orienting and
activating the Glu-497 carboxylate moiety. It is important to note
that Asn-468 is highly conserved in the aminopeptidase N family,
including those expressed by malaria parasites of humans (P.
falciparum and P. vivax), monkeys (P. knowlesi) and mice (P. berghei, P.
chabaudi and P. yeoli) (Fig. S2). Also consistent with this proposal is
that in the orientation observed in the ligand-bound simulation,
Glu-497 is in a more buried, hydrophobic environment (Fig. 3A,B)
than in the starting structure where it is in closer proximity to
polar and ionized moieties (Fig. 1C). This hydrophobic environ-
ment would facilitate the protonation of the Glu-497 carboxyl
sidechain by the nucleophilic water, since the ionized state of the
carboxylate would be energetically less favourable here.
Another novel insight from the simulations with important
implicationsforthecatalyticmechanismistheobservationthat Glu-
463 is also involved in binding the nucleophilic water; in the ligand-
bound simulation the average distance of the hydrogen bond to the
nucleophilic water was 2.5760.08 for Glu-497 and 2.6660.12 A ˚
for Glu-463. Glu-463 is part of the highly conserved GAMEN motif
(see below), and was previously implicated in both ligand binding
and catalysis by biochemical data [29,31]. Although crystal
structures elucidated its role in ligand binding by showing its
interaction with the ligand N-terminal amino nitrogen [14,17,31]
the structural basis for its role in catalysis remained unclear. Our
simulation is consistent with the biochemical data in demonstrating
how Glu-463 plays a role in catalysis i.e. by binding the nucleophilic
water and plausibly the transition state (see below), and also further
supports its role in ligand binding through its ionic interaction with
the ligand N-terminal nitrogen (Fig. 3C).
A scheme for the catalytic mechanism is proposed in Fig. 4. This
scheme is essentially the same as that proposed previously [17], but
includes further articulation of the sequence of events inferred
from our data in this study. The hydrolysis of the peptide bond
proceeds via a mechanism that comprises two sequential transition
states, I and II, that are differentiated by the distinct conforma-
tions of Glu-497, which in turn correspond to the abstraction of
the nucleophile proton and its subsequent transfer to the P19
amide of the scissile bond. In transition state I, Glu-497 (activated
by Asn-468) accepts the nucleophile proton and the tetrahedral
intermediate forms, with Glu-463 aiding in its stabilization
through the interaction with the hydroxyl moiety. In transition
state II, formation of the tetrahedral intermediate has induced a
conformational change that results in Glu-497 flipping around to
transfer its proton to the P19 amide. This conformation is
envisaged to resemble that in the starting structure (Fig. 1C),
where the Glu-497 carboxyl moiety is also able to bind the
tetrahedral intermediate hydroxyl, and thereby play a role in
facilitating the transfer of the hydroxyl proton to the P19 amide
upon collapse of the transition state.
Figure 3. Changes in interactions of active site residues in the ligand-bound complex. Diagrams of the final frame (t=75 ns) from the
simulation of the ligand-bound complex. Ligand and active site residue sidechains are shown in stick form with carbon green (ligand) or light grey
(PfA-M1), oxygen red, nitrogen blue and sulphur orange. Zn ion depicted as a purple sphere. Metallo bonds shown as purple dotted lines and
hydrogen bonds as red dotted lines. A. Interaction of Glu-497 with Asn-468. B. Interaction of Glu-526 with His-496 and Arg-489. C. Network of
interactions with the ligand N-terminal amino nitrogen and Tyr-575. GAMEN motif residues coloured yellow. D. Interaction of GAMEN backbone
amide of Gly-460 and main-chain carbonyl oxygen of Ala-461 with the ligand. The Gly-460 amide-P19 carbonyl oxygen hydrogen bond, present in the
crystal structure, is lost due to conformational changes in the loop immediately N-terminal to Gly-460. GAMEN residues shown in stick form with
carbon atoms coloured yellow.
doi:10.1371/journal.pone.0028589.g003
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In PfA-M1, residues 460–464 form the so-called GAMEN
substrate specificity motif common to many exopeptidases [14]. In
M1 aminopeptidases, the residue positioned immediately preced-
ing the GAMEN motif (Val459 in PfA-M1) interacts with the
sidechain of substrate residue P1 and likely influences substrate
specificity. The GAMEN recognition motif residues also contrib-
ute hydrogen bonds to ligand binding main-chain amide of Gly-
460, main-chain carbonyl oxygen of Ala-461 and with the side
chain of Glu-463. We found that movement of N-terminal regions
of the GAMEN motif, together with movement of the C-terminal
residues of the substrate, resulted in breaking of the interaction
between the Gly-460 amide and the backbone carbonyl oxygen of
substrate residue P29. The interaction between the main-chain
carbonyl oxygen of GAMEN residue Ala-461 with the substrate
P19 backbone amide, remained intact throughout the simulation
(Fig. 3D).
The S1 pocket loop
During our simulation of the ligand-bound state we observed
that marked alterations occurred in the region known as the S1
pocket loop, which accepts the P1 substrate residue (residues
570–575), resulting in altered interactions within the active site.
Thus, rotation of the sidechain of Tyr-575, which together with
Val-459 comprises the predominant interaction of the protease
with the substrate P1 sidechain, resulted in the formation of
hydrogen bonds between its hydroxyl group and Lys-518 and
Glu-319. This broke the hydrogen bond between Glu-463 and
Lys-518 observed in all crystal structures of aminopeptidase
N, and resulted in the formation of bidentate hydrogen
bonds between Glu-463 and substrate N-terminal amino group
(Fig. 3C).
Notably, recent structural analyses of PfA-M1 found significant
conformational changes in residues 570–575 in response to
binding derivatives of the inhibitor bestatin with larger P1 groups,
Tyr(OMe) or Tyr(OBzl). In the case of Tyr(OBzl), the Ca atom of
Glu572 moved by ,5A ˚, relative to that observed in the bestatin-
bound structure, in order to accommodate the bulkier P1
sidechain. This study also found that the S1 pocket loop (residues
570–575) is mobile with high B-factors, in contrast to previous
structural characterizations of PfA-M1 homologues, which did not
identify movement in the S1 pocket nor indicate any enhanced
mobility of this region. Our simulations are consistent with the
experimentally observed plasticity and mobility in the S1 pocket
loop, with the Ca atom of Glu572 moved by 3 A ˚ in the ligand-
bound structure at t=75 ns. In addition, our results suggest that
differences may occur in this region between the Michaelis
complex and the transition state, resulting in altered interactions
between the protein and the ligand N-terminal amino group, not
previously observed in crystal structures.
Changes in the active site are coupled to global
conformational and dynamic changes
The altered interactions observed for residues within the active
site that occurred during the simulation of the ligand-bound
complex are associated with a global network of changes in the
Figure 4. Scheme for the catalytic mechanism of M1 aminopeptidases.
doi:10.1371/journal.pone.0028589.g004
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their starting conformations, with rms deviations from the crystal
structure at 75 ns of 1.08 A ˚ and 0.96 A ˚, respectively, for Ca atoms
within each domain aligned separately. Domains II (catalytic
domain) and IV (C-terminal domain) altered internally more so,
with rms deviations of 1.37 A ˚ and 1.65 A ˚, respectively. Within the
catalytic domain II, the b-sheet within its N-terminal lobe,
together with regions of the C-terminal a-helical bundle, formed
a relatively rigid structure about which changes occurred. Most
striking, a-helix 2, which contains residues HEYFH of the
conserved zinc binding motif, pivots about its N- and C-termini,
moving the HEYFH residues away from a-helix 3, which forms
the other side of the base of the active site groove (Fig. 5A). This
change was aided by concerted alterations in a-helix 1 and the
loop at its C-terminus, and these changes allowed the interaction
of Glu-497 with Asn-468, which is on b-strand 19 (see above and
Fig. 4 regarding importance of this interaction in the catalytic
mechanism).
The other relevant change in catalytic domain II was with
respect to a-helix 4, the C-terminus of which moves away from the
active site. This occurs in concert with alterations in the loop
joining its C-terminus to a-helix 5; this includes the S1 pocket
loop, which encompasses a-helix 5a and the short loop joining it to
a-helix 5 (Fig. 5A). Together with these changes, large changes in
the two C-terminal a-helices of domain IV (25 and 26; Fig. 5B)
occurred which resulted in significant enlargement of the N-
terminal opening of the 8 A ˚-long channel to the active at the
junction of domains I and IV by which freed amino acids leave
(Fig. 6). In the apo-enzyme simulation, enlargement of the N-
terminal small opening also occurred but to a lesser extent, and
while the contribution from changes in domain IV a-helices 25
and 26 was greater, changes in the S1 pocket loop were less than in
the liganded simulation.
A flexible arm regulates peptide entry into the active site
Changes that occurred in the vicinity of the active site also
occurred in concert with rigid-body motions of domain III and
changes in a-helix 10 (residues 761–789) within domain IV. The
C-terminal residues of a-helix 10 and the immediate downstream
loop embody a flexible arm-like protuberance from the main body
of the protein proximal to the opening of the 30 A ˚-long C-
terminal channel. Over the course of the whole simulation,
residues at the C-terminus of a-helix 10 (residues 785–795)
undergo the greatest rms deviation of Ca atoms between the
starting structure and final structure (Fig. S3A), and also undergo
the greatest rms fluctuations of all residues with respect to the
starting structure (Fig. S3B). This is true for the simulations of the
ligand-bound, but not the apo-enzyme simulation (Fig. S3).
Changes in a-helix 10 and domain III appeared to be transmitted
from the catalytic domain around the outside of the large central
chamber via two distinct routes. On one side, direct interactions
occurred between a-helix 10 and domain III and a-helix 4 and the
loop at its N- and C-termini (these interactions are illustrated in
Fig. 5C). On the other side, changes that occurred at the N-
terminus of a-helix 2 and the N-terminal loop joining it to b-strand
19 were coupled to rotational movement of a-helices in domain IV
that ultimately influenced the positions a-helix 10 and domain III.
These changes are illustrated in Fig. 7.
Elastic network (EN) analysis indicated that motions of residues
at the C-terminus of a-helix 10 constitute the fundamental
dynamic mode of the protein (Fig. S4). EN analyses the energetics
of the protein’s structure and detects global dynamic modes
imprinted in the architecture; these often play functional roles
[32]. Supporting the EN analysis, principal component analysis
(PCA; see Methods) of the simulation trajectory revealed that
during the simulation of the ligand-bound complex, cyclical
concerted motions of the region of the C-terminus of a-helix 10
Figure 5. Conformational changes in the ligand-bound complex. Structural alignments of frames at t=0 and t=75 ns from the simulation of
the ligand-bound complex. Frames aligned using Ca coordinates of domain II. Ligand shown in stick form with carbon cyan, oxygen red and nitrogen
blue. Zn ion depicted as a purple sphere. Secondary structural elements as indicated. A. Catalytic domain II (t=0 green, t=75 red). C-terminal of a-
helix 1 is indicated by the arrow. B. Small N-terminal channel opening. Catalytic domain II (t=0 green, t=75 red). Domain IV (t=0 tan, t=75 mauve).
Domain I, which would partially occlude the view of the opening to the active site, has been removed for clarity. C. Coupling of conformational
changes in catalytic domain II (t=0 green, t=75 red) with changes in domains III (t=0 yellow, t=75 cyan) and IV (t=0 tan, t=75 mauve). Opening to
C-terminal channel indicated by ‘‘C’’.
doi:10.1371/journal.pone.0028589.g005
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included a large sweeping motion of the a-helix 10 ‘arm’ toward
and away from the C-terminal large opening (Fig. 8). Motions in a
direction transverse to this were also observed, indicating that the
dynamics of this region are complex.
Summary of observation and relevance to PfA-M1
function in malaria
Two 75 ns unrestrained all-atom MD simulations of PfA-M1
were performed; one of the apo-enzyme state and the other of the
protease complexed with a four-residue peptide. In order to
reproduce the coordination of the active site zinc cation observed
in crystal structures, the forcefield partial charges within the
protein and ligand Zn-coordinating moieties were adjusted such as
to preclude their substitution by a water molecule. The empirical
adjustment of the forcefield partial charges to account for charge
redistribution effects at the metal binding site is in line with recent
studies addressing this problem in MD simulations [22,23]. The
modified forcefield very accurately reproduced the distances and
geometry of the protein atoms chelating the catalytic Zn observed
in crystal structures, and induced an irregular pentahedral
coordination also consistent in terms of its geometry with crystal
structures. Together with the structural data, the results indicate
that the active site is structured sterically and electrostatically to
induce an irregular pentahedral coordination, in which two non-
protein oxygen atoms share one of the Zn’s vacant orbitals. In the
ligand-bound state, this geometry facilitates progress to the
transition state by orienting the reactants and bringing them into
close proximity.
The simulation of the ligand-bound state revealed that the
conformation of the Michaelis complex differs in significant ways
from that of the transition state, providing insights into the
catalytic mechanism. Tyr-580, which binds the ligand carbonyl
oxygen in the transition state, interacted more directly with the
ligand carbonyl carbon in the Michaelis complex, suggesting it has
a role in destabilizing the ground (reactant) state of the hydrolysis
reaction. Residue Glu-463 maintains a hydrogen bond to the Zn-
coordinating water located at the position of the attacking
nucleophile, consistent with biochemical data indicating that this
residue has a role in catalysis. Finally, we observed in the ligand-
bound simulations that the conformation of the catalytic domain
in the Michaelis complex differed from the apo-enzyme and the
reported inhibitor-bound crystal structures, resulting in the
Figure 6. Opening of the N-terminal small channel. Surface representation (blue) of the starting structure (left) and the ligand-bound structure
at t=75 ns (right). Ligand is shown in stick form with carbon yellow, oxygen red and nitrogen blue. The N-terminal phenylalanine residue of the
ligand is visible in the opened channel at t=75 ns (right).
doi:10.1371/journal.pone.0028589.g006
Figure 7. Propagation of conformational changes from the
active site to domain III and a-helix 10. Two roughly orthogonal
views of PfA-M1 with secondary structural elements coloured in a
spectrum pattern, blue to red, according to residue number. The
internal chamber within the protein is shown in space filling
representation and coloured violet. N-terminal channel indicated by
an ‘‘N’’. Left panel: Loop between b-strand 19 and a-helix 2 in domain II
indicated by ‘‘L’’. a-helices 11–19 are coloured orange through yellow
and appear in the lower right quadrant. This region rotates in the
direction of the oblique arrow. Domain III (lower left) moves in the
direction of the small horizontal arrow. Right panel: a-helix 4 from
domain II moves down and to the right, impinging on a-helix 10 at its
N-terminus and also via a-helix 13.
doi:10.1371/journal.pone.0028589.g007
Figure 8. Concerted motions of the a-helix 10 C-terminal arm
toward the large C-terminal channel. Two views of the overlayed
maximum (orange) and minimum (slate) projection structures of PCA
eigenvector 2 from the simulation of the ligand-bound complex.
Opening to the C-terminal channel indicated by a ‘‘C’’.
doi:10.1371/journal.pone.0028589.g008
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such that Glu-497 also maintained a hydrogen bond to the
putative nucleophilic water. This configuration is consistent with
the expected role of Glu-497 as the catalytic base, and locates the
residue in a buried hydrophobic environment, which is energet-
ically favorable to it accepting a proton from the attacking
nucleophilic water. The results suggest a two-step catalytic
mechanism, whereby formation of the tetrahedral transition state
induces a conformational change in the catalytic domain such that
Glu-497 rotates, enabling it to donate its proton to the leaving
amide of the ligand, to complete the hydrolysis reaction (see Fig. 4).
The simulation of both the ligand-bound complex and apo-
enzyme state revealed that changes in conformation in the
catalytic domain are coupled to global conformational changes
in the protein. These appear to be driven by changes in
conformation at the N-terminus of a-helix 2 and at the C-
terminus of a-helix 3, a-helix 4 and the downstream loop joining
to a-helix 5. Near the active site, this resulted in opening of the
shallow 8 A ˚-long N-terminal small channel located at the junction
of domains I and IV which is expected to be the point of exit for
the free amino acid following proteolysis. Conformational changes
are also propagated from the catalytic domain toward a-helix 10
via two routes around the central cavity. The C-terminus of a-helix
10 and downstream loop proximal to the opening of the 30 A ˚-long
C-terminal channel undergoes the largest fluctuations within the
protein and EN analysis suggests that these are of major functional
significance.
The large size of the internal 30 A ˚-long C-terminal channel
invites questions as to its function; it could be capable of enclosing
a continuous peptide that reaches the entrance at the C-terminal
opening and beyond. It seems reasonable to suggest that the PfA-
M1 can digest peptides of 8–10 residues or more and that the
function of the a-helix 10 arm is to move the peptide into the
cavity as free amino acids are released at the N-terminal small
opening. Indeed the PCA analysis of the simulation trajectories
indicated that changes in the catalytic domain are correlated with
changes in a-helix 10. Thus, after the N-terminal small channel
opens to release product, the a-helix 10 could facilitate movement
of the peptide ligand one amino acid into the cavity by acting in a
‘ratchet-like’ fashion. Alternatively, or additionally, the internal
chamber may act as a kind of vestibule or ‘waiting room’, for
smaller peptides that get shunted along toward the active site like
an assembly line. Digestion of host hemoglobin within the
digestive vacuole by a series of endopeptidases and exopeptidases
likely yields peptides of various sizes but the exact size of peptides
that are transported to the cytoplasm for further processing by the
M1 aminopeptidase is not known. However, when human
hemoglobin was incubated with lysates of P. falciparum digestive
vacuole a series of discrete peptide fragments were generated with
cleavage sites an average of 8.4 amino acids apart [10].
Nevertheless, we suggest there is a concerted conformational
dynamic between the ‘ratcheted’ movements in a-helix 10,
movements of peptides along the 30 A ˚-long C-terminal channel
towards the active site, hydrolysis of the N-terminal substrate
amino acid and its exit via the 8 A ˚-long N-terminal small channel
and widening of the opening.
In showing how the Michaelis complex differs from the
transition state conformation, the results provide insights that
could aid in the design of agents to inhibit this class of enzyme that
target the active site. In the case of PfA-M1, however, due to its
homology with various mammalian aminopeptidase N, drugs may
need to be targeted to more sequence-diverse regions to reduce
off-target side effects. Our results indicate that the large central
cavity, particularly areas close to the active site that bind the P1-39
substrate sidechains could be fruitful areas of investigation in this
regard. In addition, the results support the flexibility and plasticity
of the S1 pocket loop inferred from a recent structural analysis
[33], and thus support the idea that this pocket may also be
exploited in the development of new therapeutic agents against
malaria.
Methods
Two 75 ns all atom MD simulations of PfA-M1 were
performed, one of the unliganded (apo-enzyme) state and the
other in which the protein was complexed with a four-residue
peptide bound in the active site. Starting coordinates were the
1.65 A ˚ resolution crystallographic structure of PfA-M1, complexed
with the inhibitor bestatin [14]; PDB code 3EBH). Seven
engineered mutations were reversed to the wild type sequence,
as indicated in the PDB file header (3EBH). Initial coordinates for
a template peptide substrate (PHE-LEU-ALA) were derived from
coordinates of the bestatin inhibitor bound in the active site. This
initial peptide was minimized while bound to PfA-M1 using the
equilibration protocol described below. The equilibrated peptide
was then extended by one serine residue at its C-terminus, using
the coordinate generation function in the psfgen program [34],
and then re-equilibrated. Finally, the C-terminal residue of the
substrate was N-methylamidated and re-equilibrated; the resultant
four-residue peptide PHE-LEU-ALA-SER was used in the
simulation of the ligand-bound complex. The protein was
optimally oriented to minimize cell volume [35] and solvated in
a truncated octahedral periodic cell with a minimum of 20 A ˚
between periodic images of the protein; the system was neutralized
with a 0.2 M NaCl solution.
MD simulations were carried out with NAMD 2.6 [34] using
the CHARMM27 force field with w/y cross-term map corrections
[36]. Water molecules were simulated with the TIP3P model [37].
Simulation conditions were maintained at 1.0 atm constant
pressure by the Nose ´-Hoover Langevin piston method [38,39]
and at 310 K constant temperature by Langevin dynamics with a
damping coefficient at 5 ps
21. The time step used for the
simulations was 1 fs. A cutoff of 11 A ˚, with a switching function
between 9.5 and 11 A ˚, was used for short-range non-bonded
interactions. Long-range electrostatic interactions were computed
using the particle mesh Ewald method [40] with a grid density of
approximately 1/A ˚. The mollified impulse method [41] was used
allowing a multiple time-stepping algorithm, with interactions
involving covalent bonds computed every time step, short-range
non-bonded interactions every two time steps, and long-range
electrostatic forces every 6 time steps.
The catalytic zinc was simulated using a five-atom tetrahedral
zinc divalent cation, comprising a centre atom and four identical
atoms located at the apices of a regular tetrahedron. Parameters
for the bonded interactions of the zinc apex atoms were as for the
dummy atoms in [21]. A mass of 3 and a charge of +0.5e was
assigned to the apex atoms. Dummy atoms are not supported in
NAMD 2.6 and a Leonard-Jones parameter of e=0.001 kcal/
mol, r=0.1 A ˚ was assigned to the apex atoms. A 1fs timestep was
required for calculation of bonded interactions of the apex atoms.
For the central zinc atom, the standard CHARMM27 parameters
were used, but with a charge of zero.
In preliminary simulations using this model, water molecules
eventually replaced the two histidine Ne2 atoms and the ligand P1
carbonyl oxygen in the first coordination sphere of the zinc ion.
Increasing the partial charge on the two Zn-coordinating histidine
Ne2 atoms from 20.7 to 20.92, and on the ligand P1 carbonyl
oxygen from 20.51 to 20.76, was minimally required to maintain
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coordinating histidines, the residual charge was distributed over
the histidyl moiety, while for the ligand the charge of the carbonyl
carbon of the scissile C-O bond was increased from +0.51 to +0.76
to maintain electrical neutrality. Adjustment of the forcefield
partial charges to account for polarisation effects at the metal
binding site is in line with recent studies addressing this problem in
MD simulations [22,23]. In addition, increased polarisation of the
ligand scissile C-O bond is consistent with the expected catalytic
mechanism. To marginally increase the average distance between
the coordinating carboxylate oxygen of E519 and the Zn atom,
bringing it closer to that observed in crystal structures of related
enzymes, Leonard-Jones interactions between all zinc atoms and
glutamate and aspartate sidechain oxygens were adjusted using the
NBFIX facility, such that type OC atoms (carboxylate oxygens)
were parameterised at e=0.1521 kcal/mol, r=3.54 A ˚, which are
the nonbonded parameters for hydroxyl oxygens in the
CHARMM27 forcefield.
During the equilibration phase of the ligand-bound complex,
harmonic restraints with a force constant of 10 kcal/mol were
applied between the proximal zinc apex atom and the sidechain
carboxylate oxygen of Zn-coordinating residue 519, between the
ligand scissile bond Zn-coordinating carbonyl oxygen and the
central zinc atom, and between the active site Zn-coordinating
nuclephilic water oxygen and the central zinc atom. The solvated
starting structure was minimized using conjugate gradient
minimization to a 0.5 kcal/(mol?A ˚) r.m.s. gradient with all enzyme
heavy atoms fixed. The unrestrained atoms were then further
minimized during a 50 ps molecular dynamics run at 310 K. This
starting model was then minimized with harmonic positional
constraints on the NCaCO backbone of the protein and Ca atoms
of ligand residues 3–4. A 100 kcal/(mol?A ˚ 2) force constant was
used to minimise the system to a 0.5 kcal/(mol?A ˚) r.m.s. gradient.
The harmonic positional constraints were gradually removed by
subsequent minimizations to a 0.1 kcal/(mol?A ˚) r.m.s. gradient,
scaling the initial force constants by factors of 0.5, 0.15, 0.05, and
0. The minimized structure was then heated from 50 K to 310 K
in steps of 25 K using velocity reassignment during a 30 ps
molecular dynamics run. For the ligand-bound system, the force
constant of the harmonic distance restraints imposed on the Zn
atoms during the above equilibration were reduced to 5 kcal/mol,
and a short 0.5 ns MD run was performed. The two equilibrated
systems were then used for production runs of 75 M integration
steps with no restraints. Both simulations remained stable to
completion. For analysis, coordinates were recorded every 5000
timesteps (5 ps).
Principal component analysis (PCA) of the Ca atom coordinate
trajectory was used to identify and characterise global conforma-
tional transitions. PCA defines a set of eigenvectors (EVs) derived
from the matrix of pairwise correlated motion of atoms. EVs are
ranked according to the amplitude of the protein motions they
describe and in general, the first 1 to 4 EVs account for the most
concerted 50% or more of protein fluctuations. PCA of the
simulation a-carbon atom trajectories was performed using the
GROMACS package [42].
Elastic network analysis was performed on the PfA-M1 structure
(3EBH) using the online facility [43] available at: http://ignm.
ccbb.pitt.edu/, using the Anisotropic Network Model (ANM; [44])
with default settings. All structural figures were prepared using
PyMol (http://www.pymol.org/). The programs VMD [45],
(available at http://www.ks.uiuc.edu/Research/vmd/), Xplor-
NIH [46] and Simulaid (http://atlas.physbio.mssm.edu/,mezei/)
were used in the preparation and analysis of the simulation system.
Supporting Information
Figure S1 Loci of Zn-coordinating water molecules in
crystal structures of aminopeptidase N. Structural align-
ment of the E. coli pepN active site from two apo structures: 2HPO
(green; [16]) and 2DQ6 (cyan; [17]). Zn coloured blue (2HPO)
and red (2DQ6). Residues numbered as in PfA-M1. Metallo bonds
in 2HPO shown by blue dotted lines. Hydrogen bonds to water
molecules indicated by red dotted lines.
(TIF)
Figure S2 Primary sequence alignment of M1 amino-
peptidases from various Plasmodium species. Identical
residues are highlighted in red and conservatively substituted
amino acids are shown in red text. The putative transmembrane
domain is boxed in orange and the GAMEN substrate-recognition
motif is boxed in black. The zinc-binding motif is underlined and
the catalytic residues are indicated with arrowheads. Asn-468 and
Tyr-580 are indicated (asterisks).
(TIF)
Figure S3 Per residue changes during the simulations.
A. Per residue rms deviation relative to the starting structure after
alignment using coordinates of the Ca atoms of domain II (392–
649). Ligand-bound complex blue, apo red. B. Per residue rms
fluctuations relative to the starting structure after alignment
using coordinates of all Ca atoms. Ligand-bound complex blue,
apo red.
(TIF)
Figure S4 Elastic network analysis of PfA-M1. Per residue
fluctuations due to slowmodes 1–3 from the ANM analysis of PfA-
M1 (PDB 3EBH). Units of fluctuations are relative only. Mode 1,
blue; mode 2, red; mode 3, yellow.
(TIF)
Table S1 This table shows the mean distances between
the Zn apex atoms and the proximal coordinating
atoms.
(DOCX)
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